04.25.25 -- Why You Need A Raw Material Control Strategy

Overcoming the challenges of manufacturing and administering a complex product to any patient is critical for delivering cell therapies.

While barrier films in bags can be useful for cold chain applications, they do not fully protect against gas ingress and ignore other sources of permeability.

This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.

Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.

Stay ahead in the rapidly evolving field of siRNA therapeutics by exploring the latest clinical trends, breakthrough delivery technologies, combination strategies, and global regulatory pathways.

Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine.

This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.

Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.

By integrating patient feedback early in the design phase, trials can enhance recruitment and retention rates, ensuring both regulatory compliance and participant well-being.

By combining strategic foresight, operational efficiency, and financial incentives, Avance Clinical empowers biotech companies to navigate funding challenges and bring innovative therapies to market.